APOE and Alzheimer disease: These encouraging results demonstrate that the adopted integrated virtual and experimental protocol, together with our innovative consensus ranking scheme, may prove to be a useful tool for the identification of novel hits that can be developed into potent ApoE-targeted therapies for AD.